Extracellular vesicles and cardiovascular disease interlink: A new clinical perspective in cardiology

References

[1] ShaoH, Im H, CastroCM, et al. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118(4):1917-1950.

[2] KalluriR, LeBleuVS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.

[3] VaduganathanM, MensahGA, TurcoJV, et al. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361-2371.

[4] GaoXF, WangZM, WangF, et al. Exosomes in coronary artery disease. Int J Biol Sci. 2019;15(11):2461-2470.

[5] ChengM, YangJ, ZhaoX, et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat Commun. 2019;10(1):959.

[6] SayedAS, XiaK, SalmaU, Yang T, PengJ. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 2014;23(6):503-510.

[7] ShiC, XieH, MaY, et al. Nanoscale technologies in highly sensitive diagnosis of cardiovascular diseases. Front Bioeng Biotechnol. 2020;8:531.

[8] Moreira-CostaL, BarrosAS, LourençoAP, et al. Exosome-derived mediators as potential biomarkers for cardiovascular diseases: a network approach. Proteomes. 2021;9(1):8.

[9] LiuC, BayadoN, HeD, et al. Therapeutic applications of extracellular vesicles for myocardial repair. Front Cardiovasc Med. 2021;8:758050.

[10] HanC, YangJ, SunJ, et al. Extracellular vesicles in cardiovascular disease: biological functions and therapeutic implications. Pharmacol Ther. 2022;233:108025.

[11] MoralesRT, KoJ. Future of digital assays to resolve clinical heterogeneity of single extracellular vesicles. ACS Nano. 2022;16(8):11619-11645.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.